Effects of antipsychotic drugs on energy metabolism

Schizophrenia (SCZ) is a complex neuropsychiatric disorder associated with altered bioenergetic pathways and mitochondrial dysfunction. Antipsychotic medications, both first and second-generation, are commonly prescribed to manage SCZ symptoms, but their direct impact on mitochondrial function remai...

Full description

Saved in:
Bibliographic Details
Published inEuropean archives of psychiatry and clinical neuroscience Vol. 274; no. 5; pp. 1125 - 1135
Main Authors Panizzutti, Bruna, Bortolasci, Chiara C., Spolding, Briana, Kidnapillai, Srisaiyini, Connor, Timothy, Martin, Sheree D., Truong, Trang T. T., Liu, Zoe S. J., Gray, Laura, Kowalski, Greg M., McGee, Sean L., Kim, Jee Hyun, Berk, Michael, Walder, Ken
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer Berlin Heidelberg 01.08.2024
Springer
Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Schizophrenia (SCZ) is a complex neuropsychiatric disorder associated with altered bioenergetic pathways and mitochondrial dysfunction. Antipsychotic medications, both first and second-generation, are commonly prescribed to manage SCZ symptoms, but their direct impact on mitochondrial function remains poorly understood. In this study, we investigated the effects of commonly prescribed antipsychotics on bioenergetic pathways in cultured neurons. We examined the impact of risperidone, aripiprazole, amisulpride, and clozapine on gene expression, mitochondrial bioenergetic profile, and targeted metabolomics after 24-h treatment, using RNA-seq, Seahorse XF24 Flux Analyser, and gas chromatography–mass spectrometry (GC–MS), respectively. Risperidone treatment reduced the expression of genes involved in oxidative phosphorylation, the tricarboxylic acid cycle, and glycolysis pathways, and it showed a tendency to decrease basal mitochondrial respiration. Aripiprazole led to dose-dependent reductions in various mitochondrial function parameters without significantly affecting gene expression. Aripiprazole, amisulpride and clozapine treatment showed an effect on the tricarboxylic acid cycle metabolism, leading to more abundant metabolite levels. Antipsychotic drug effects on mitochondrial function in SCZ are multifaceted. While some drugs have greater effects on gene expression, others appear to exert their effects through enzymatic post-translational or allosteric modification of enzymatic activity. Understanding these effects is crucial for optimising treatment strategies for SCZ. Novel therapeutic interventions targeting energy metabolism by post-transcriptional pathways might be more effective as these can more directly and efficiently regulate energy production.
AbstractList Schizophrenia (SCZ) is a complex neuropsychiatric disorder associated with altered bioenergetic pathways and mitochondrial dysfunction. Antipsychotic medications, both first and second-generation, are commonly prescribed to manage SCZ symptoms, but their direct impact on mitochondrial function remains poorly understood. In this study, we investigated the effects of commonly prescribed antipsychotics on bioenergetic pathways in cultured neurons. We examined the impact of risperidone, aripiprazole, amisulpride, and clozapine on gene expression, mitochondrial bioenergetic profile, and targeted metabolomics after 24-h treatment, using RNA-seq, Seahorse XF24 Flux Analyser, and gas chromatography-mass spectrometry (GC-MS), respectively. Risperidone treatment reduced the expression of genes involved in oxidative phosphorylation, the tricarboxylic acid cycle, and glycolysis pathways, and it showed a tendency to decrease basal mitochondrial respiration. Aripiprazole led to dose-dependent reductions in various mitochondrial function parameters without significantly affecting gene expression. Aripiprazole, amisulpride and clozapine treatment showed an effect on the tricarboxylic acid cycle metabolism, leading to more abundant metabolite levels. Antipsychotic drug effects on mitochondrial function in SCZ are multifaceted. While some drugs have greater effects on gene expression, others appear to exert their effects through enzymatic post-translational or allosteric modification of enzymatic activity. Understanding these effects is crucial for optimising treatment strategies for SCZ. Novel therapeutic interventions targeting energy metabolism by post-transcriptional pathways might be more effective as these can more directly and efficiently regulate energy production.
Schizophrenia (SCZ) is a complex neuropsychiatric disorder associated with altered bioenergetic pathways and mitochondrial dysfunction. Antipsychotic medications, both first and second-generation, are commonly prescribed to manage SCZ symptoms, but their direct impact on mitochondrial function remains poorly understood. In this study, we investigated the effects of commonly prescribed antipsychotics on bioenergetic pathways in cultured neurons. We examined the impact of risperidone, aripiprazole, amisulpride, and clozapine on gene expression, mitochondrial bioenergetic profile, and targeted metabolomics after 24-h treatment, using RNA-seq, Seahorse XF24 Flux Analyser, and gas chromatography-mass spectrometry (GC-MS), respectively. Risperidone treatment reduced the expression of genes involved in oxidative phosphorylation, the tricarboxylic acid cycle, and glycolysis pathways, and it showed a tendency to decrease basal mitochondrial respiration. Aripiprazole led to dose-dependent reductions in various mitochondrial function parameters without significantly affecting gene expression. Aripiprazole, amisulpride and clozapine treatment showed an effect on the tricarboxylic acid cycle metabolism, leading to more abundant metabolite levels. Antipsychotic drug effects on mitochondrial function in SCZ are multifaceted. While some drugs have greater effects on gene expression, others appear to exert their effects through enzymatic post-translational or allosteric modification of enzymatic activity. Understanding these effects is crucial for optimising treatment strategies for SCZ. Novel therapeutic interventions targeting energy metabolism by post-transcriptional pathways might be more effective as these can more directly and efficiently regulate energy production.Schizophrenia (SCZ) is a complex neuropsychiatric disorder associated with altered bioenergetic pathways and mitochondrial dysfunction. Antipsychotic medications, both first and second-generation, are commonly prescribed to manage SCZ symptoms, but their direct impact on mitochondrial function remains poorly understood. In this study, we investigated the effects of commonly prescribed antipsychotics on bioenergetic pathways in cultured neurons. We examined the impact of risperidone, aripiprazole, amisulpride, and clozapine on gene expression, mitochondrial bioenergetic profile, and targeted metabolomics after 24-h treatment, using RNA-seq, Seahorse XF24 Flux Analyser, and gas chromatography-mass spectrometry (GC-MS), respectively. Risperidone treatment reduced the expression of genes involved in oxidative phosphorylation, the tricarboxylic acid cycle, and glycolysis pathways, and it showed a tendency to decrease basal mitochondrial respiration. Aripiprazole led to dose-dependent reductions in various mitochondrial function parameters without significantly affecting gene expression. Aripiprazole, amisulpride and clozapine treatment showed an effect on the tricarboxylic acid cycle metabolism, leading to more abundant metabolite levels. Antipsychotic drug effects on mitochondrial function in SCZ are multifaceted. While some drugs have greater effects on gene expression, others appear to exert their effects through enzymatic post-translational or allosteric modification of enzymatic activity. Understanding these effects is crucial for optimising treatment strategies for SCZ. Novel therapeutic interventions targeting energy metabolism by post-transcriptional pathways might be more effective as these can more directly and efficiently regulate energy production.
Audience Academic
Author Liu, Zoe S. J.
Panizzutti, Bruna
Connor, Timothy
Truong, Trang T. T.
Walder, Ken
Gray, Laura
Spolding, Briana
Kowalski, Greg M.
McGee, Sean L.
Berk, Michael
Kidnapillai, Srisaiyini
Kim, Jee Hyun
Bortolasci, Chiara C.
Martin, Sheree D.
Author_xml – sequence: 1
  givenname: Bruna
  orcidid: 0000-0002-8825-734X
  surname: Panizzutti
  fullname: Panizzutti, Bruna
  organization: Deakin University, School of Medicine, IMPACT, The Institute for Mental and Physical Health and Clinical Translation
– sequence: 2
  givenname: Chiara C.
  orcidid: 0000-0002-0794-6363
  surname: Bortolasci
  fullname: Bortolasci, Chiara C.
  organization: Deakin University, School of Medicine, IMPACT, The Institute for Mental and Physical Health and Clinical Translation
– sequence: 3
  givenname: Briana
  surname: Spolding
  fullname: Spolding, Briana
  organization: Deakin University, School of Medicine, IMPACT, The Institute for Mental and Physical Health and Clinical Translation
– sequence: 4
  givenname: Srisaiyini
  orcidid: 0000-0001-5313-9813
  surname: Kidnapillai
  fullname: Kidnapillai, Srisaiyini
  organization: Deakin University, School of Medicine, IMPACT, The Institute for Mental and Physical Health and Clinical Translation
– sequence: 5
  givenname: Timothy
  surname: Connor
  fullname: Connor, Timothy
  organization: Deakin University, School of Medicine, IMPACT, The Institute for Mental and Physical Health and Clinical Translation
– sequence: 6
  givenname: Sheree D.
  surname: Martin
  fullname: Martin, Sheree D.
  organization: Deakin University, School of Medicine, IMPACT, The Institute for Mental and Physical Health and Clinical Translation
– sequence: 7
  givenname: Trang T. T.
  orcidid: 0000-0001-9301-5911
  surname: Truong
  fullname: Truong, Trang T. T.
  organization: Deakin University, School of Medicine, IMPACT, The Institute for Mental and Physical Health and Clinical Translation
– sequence: 8
  givenname: Zoe S. J.
  orcidid: 0000-0002-0269-0119
  surname: Liu
  fullname: Liu, Zoe S. J.
  organization: Deakin University, School of Medicine, IMPACT, The Institute for Mental and Physical Health and Clinical Translation
– sequence: 9
  givenname: Laura
  surname: Gray
  fullname: Gray, Laura
  organization: Deakin University, School of Medicine, IMPACT, The Institute for Mental and Physical Health and Clinical Translation
– sequence: 10
  givenname: Greg M.
  orcidid: 0000-0002-1599-017X
  surname: Kowalski
  fullname: Kowalski, Greg M.
  organization: Metabolic Research Unit, School of Medicine, Institute for Physical Activity and Nutrition
– sequence: 11
  givenname: Sean L.
  orcidid: 0000-0001-6953-106X
  surname: McGee
  fullname: McGee, Sean L.
  organization: Deakin University, School of Medicine, IMPACT, The Institute for Mental and Physical Health and Clinical Translation
– sequence: 12
  givenname: Jee Hyun
  orcidid: 0000-0002-1299-4300
  surname: Kim
  fullname: Kim, Jee Hyun
  organization: Deakin University, School of Medicine, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, Florey Institute of Neuroscience and Mental Health
– sequence: 13
  givenname: Michael
  orcidid: 0000-0002-5554-6946
  surname: Berk
  fullname: Berk, Michael
  organization: Deakin University, School of Medicine, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, Barwon Health, University Hospital Geelong, Department of Psychiatry, The University of Melbourne, Orygen, The National Centre for Excellence in Youth Mental Health, Florey Institute of Neuroscience and Mental Health
– sequence: 14
  givenname: Ken
  orcidid: 0000-0002-6758-4763
  surname: Walder
  fullname: Walder, Ken
  email: ken.walder@deakin.edu.au
  organization: Deakin University, School of Medicine, IMPACT, The Institute for Mental and Physical Health and Clinical Translation
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38072867$$D View this record in MEDLINE/PubMed
BookMark eNp9kU1rFTEUhoNU7G31D7iQATdupp58TWaWpbQqFNzoOuTzmjKTXJPM4v57c3tbiqWULAKH530TznOGTmKKDqGPGC4wgPhaABgMPRDaAxZE9OQN2mBGaT-yCZ-gDUwMekwpO0VnpdwBAOYE3qFTOoIg4yA2iF5770wtXfKdijXsyt78STWYzuZ128axc9Hl7b5bXFU6zaEs79Fbr-biPjzc5-j3zfWvq-_97c9vP64ub3vDGKk9odxoxhU3ylqPKbaWqUEoZ7SmmBun9ci4BsoI517AZDU2TFGh_cQsdfQcfTn27nL6u7pS5RKKcfOsoktrkWQCMlEx8bGhn5-hd2nNsf1OUhADjHwiwxO1VbOTIfpUszKHUnk5ApBB4IE06uIFqh3rlmCaAh_a_L_Ap4fHV704K3c5LCrv5eOWGzAeAZNTKdl5aUJVNaTYmsMsMciDUHkUKptQeS9UHrrJs-hj-6shegyVBsety0_beCX1D-nIr1o
CitedBy_id crossref_primary_10_3390_cells13090762
crossref_primary_10_1080_15622975_2025_2453181
Cites_doi 10.1186/s12888-014-0268-x
10.1093/bioinformatics/btu170
10.1038/mp.2013.67
10.1016/j.biopsych.2008.03.004
10.1016/j.intimp.2019.106093
10.1093/bioinformatics/btp616
10.1001/jamapsychiatry.2013.2287
10.1016/j.pnpbp.2012.10.017
10.1080/15622975.2020.1755450
10.1080/07853890801923753
10.3390/antiox12040975
10.1038/mp.2016.75
10.1038/mp.2014.22
10.3390/ijms23137180
10.1080/15622975.2018.1492734
10.1016/j.biopsych.2005.03.031
10.1016/S0140-6736(17)32130-X
10.3390/ijms22137164
10.1016/j.schres.2019.09.007
10.1016/j.biopsych.2011.01.010
10.1093/hmg/ddi022
10.1016/j.schres.2017.06.046
10.1038/s41598-020-69207-4
10.1016/j.euroneuro.2018.01.004
10.1021/acs.jproteome.1c00504
10.1016/j.molmet.2014.02.001
10.1186/1471-244X-9-57
10.15407/ubj88.04.005
10.1016/j.bbabio.2007.10.006
10.1172/jci.insight.125657
10.1017/S003329172200174X
10.3389/fpsyt.2022.950602
10.1016/j.mito.2020.11.009
10.1038/s41467-019-13668-3
10.3727/096368911X600957
10.1046/j.1471-4159.2002.01263.x
10.1038/s41467-022-31436-8
10.1016/j.neubiorev.2014.11.005
10.1146/annurev-clinpsy-032813-153657
10.1016/j.neulet.2004.09.070
10.1186/s40170-019-0207-x
10.1002/syn.22276
10.1089/omi.2011.0118
10.1111/j.2517-6161.1995.tb02031.x
10.1073/pnas.0506580102
10.1038/sj.mp.4001511
10.1038/s41586-022-04556-w
10.1038/tp.2012.13
10.1007/s12035-021-02498-4
10.1093/bioinformatics/bts635
ContentType Journal Article
Copyright The Author(s), under exclusive licence to Springer-Verlag GmbH Germany 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.
COPYRIGHT 2024 Springer
Copyright_xml – notice: The Author(s), under exclusive licence to Springer-Verlag GmbH Germany 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
– notice: 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.
– notice: COPYRIGHT 2024 Springer
DBID AAYXX
CITATION
NPM
3V.
7TK
7X7
7XB
88E
88G
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
K9.
M0S
M1P
M2M
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
PSYQQ
Q9U
7X8
DOI 10.1007/s00406-023-01727-2
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
Neurosciences Abstracts
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central (New)
ProQuest One
ProQuest Central Korea
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
Psychology Database (ProQuest)
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
ProQuest One Psychology
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Central Basic
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
ProQuest One Psychology

MEDLINE - Academic
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1433-8491
EndPage 1135
ExternalDocumentID A800267162
38072867
10_1007_s00406_023_01727_2
Genre Journal Article
GrantInformation_xml – fundername: National Health and Medical Research Council
  grantid: GNT1078928; 1156072; 2017131
  funderid: http://dx.doi.org/10.13039/501100000925
– fundername: National Health and Medical Research Council
  grantid: 1156072
– fundername: National Health and Medical Research Council
  grantid: GNT1078928
– fundername: National Health and Medical Research Council
  grantid: 2017131
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-Y2
-~C
.86
.GJ
.VR
06C
06D
0R~
0VY
1N0
2.D
203
28-
29G
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
36B
3O-
3V.
4.4
406
408
409
40D
40E
53G
5GY
5QI
5RE
5VS
67Z
6NX
7X7
88E
8AO
8FI
8FJ
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AACDK
AAHNG
AAIAL
AAJBT
AAJKR
AANXM
AANZL
AARHV
AARTL
AASML
AATNV
AATVU
AAUYE
AAWCG
AAYIU
AAYQN
AAYTO
AAYZH
ABAKF
ABBBX
ABBXA
ABDBF
ABDZT
ABECU
ABFTV
ABHLI
ABHQN
ABIPD
ABIVO
ABJNI
ABJOX
ABKCH
ABKTR
ABLJU
ABMNI
ABMQK
ABNWP
ABPLI
ABQBU
ABQSL
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABWNU
ABXPI
ACAOD
ACBXY
ACDTI
ACGFS
ACHSB
ACHXU
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPIV
ACPRK
ACUDM
ACUHS
ACZOJ
ADBBV
ADHIR
ADINQ
ADJJI
ADKNI
ADKPE
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEBTG
AEFIE
AEFQL
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AETLH
AEVLU
AEXYK
AFBBN
AFEXP
AFFNX
AFKRA
AFLOW
AFQWF
AFWTZ
AFZKB
AGAYW
AGDGC
AGGDS
AGJBK
AGMZJ
AGQEE
AGQMX
AGRTI
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIGIU
AIIXL
AILAN
AITGF
AJBLW
AJRNO
AJZVZ
AKMHD
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AOCGG
ARMRJ
AXYYD
AZFZN
AZQEC
B-.
B0M
BA0
BBWZM
BDATZ
BENPR
BGNMA
BPHCQ
BSONS
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
DWQXO
EAD
EAP
EBC
EBD
EBLON
EBS
EIOEI
EJD
EMB
EMK
EMOBN
EN4
EPL
EPS
ESBYG
ESX
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNUQQ
GNWQR
GQ6
GQ7
GQ8
GRRUI
GXS
H13
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
IAO
IHE
IHR
IJ-
IKXTQ
IMOTQ
IPY
ITC
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAS
LLZTM
M1P
M2M
M4Y
MA-
N2Q
N9A
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
P19
P9S
PF0
PQQKQ
PROAC
PSQYO
PSYQQ
PT4
PT5
Q2X
QOK
QOR
QOS
R89
R9I
RHV
RIG
RNI
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TSG
TSK
TSV
TT1
TUC
TUS
U2A
U9L
UG4
UKHRP
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
YLTOR
Z45
Z7U
Z7W
Z82
Z87
Z8O
Z8Q
Z8V
Z91
ZMTXR
ZOVNA
ZXP
~8M
~EX
AAPKM
AAYXX
ABBRH
ABDBE
ABFSG
ACSTC
ADHKG
AEZWR
AFDZB
AFHIU
AFOHR
AGQPQ
AHPBZ
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
NPM
ABRTQ
7TK
7XB
8FK
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQUKI
PRINS
Q9U
7X8
ID FETCH-LOGICAL-c442t-235cb45a5caddf131dd4a67aecbb315cebb845b034255f709db1c4a37bf94d3e3
IEDL.DBID 7X7
ISSN 0940-1334
1433-8491
IngestDate Tue Aug 05 08:49:35 EDT 2025
Sat Aug 16 19:41:52 EDT 2025
Wed Aug 06 19:37:57 EDT 2025
Tue Aug 05 03:50:57 EDT 2025
Wed Feb 19 02:08:01 EST 2025
Tue Jul 01 04:31:22 EDT 2025
Thu Apr 24 22:59:46 EDT 2025
Fri Feb 21 02:40:06 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Antipsychotics
Energy metabolism
Mitochondria
Neuroscience
Neurons
Mental health
Schizophrenia
Psychiatry
Language English
License 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c442t-235cb45a5caddf131dd4a67aecbb315cebb845b034255f709db1c4a37bf94d3e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-5313-9813
0000-0002-0269-0119
0000-0002-1299-4300
0000-0001-9301-5911
0000-0002-1599-017X
0000-0002-6758-4763
0000-0002-5554-6946
0000-0001-6953-106X
0000-0002-8825-734X
0000-0002-0794-6363
PMID 38072867
PQID 3076085926
PQPubID 47319
PageCount 11
ParticipantIDs proquest_miscellaneous_2902937958
proquest_journals_3076085926
gale_infotracmisc_A800267162
gale_infotracacademiconefile_A800267162
pubmed_primary_38072867
crossref_citationtrail_10_1007_s00406_023_01727_2
crossref_primary_10_1007_s00406_023_01727_2
springer_journals_10_1007_s00406_023_01727_2
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-08-01
PublicationDateYYYYMMDD 2024-08-01
PublicationDate_xml – month: 08
  year: 2024
  text: 2024-08-01
  day: 01
PublicationDecade 2020
PublicationPlace Berlin/Heidelberg
PublicationPlace_xml – name: Berlin/Heidelberg
– name: Germany
– name: Heidelberg
PublicationTitle European archives of psychiatry and clinical neuroscience
PublicationTitleAbbrev Eur Arch Psychiatry Clin Neurosci
PublicationTitleAlternate Eur Arch Psychiatry Clin Neurosci
PublicationYear 2024
Publisher Springer Berlin Heidelberg
Springer
Springer Nature B.V
Publisher_xml – name: Springer Berlin Heidelberg
– name: Springer
– name: Springer Nature B.V
References Benjamini, Hochberg (CR29) 1995; 57
Brenner-Lavie (CR43) 2008; 1777
Bolger, Lohse, Usadel (CR25) 2014; 30
Singh (CR10) 2022; 604
Pandya, Howell, Pillai (CR17) 2013; 46
Mittal (CR47) 2017; 187
Robicsek (CR40) 2013; 18
Shao (CR36) 2008; 40
Babich, Shlykov, Kushnarova, Kosterin (CR45) 2016; 88
Megiorni, Mora, Indovina, Mazzilli (CR20) 2005; 373
Martin, McGee (CR33) 2019; 7
Kidnapillai (CR22) 2018
Ben-Shachar (CR7) 2002; 83
Gonzalez-Liencres (CR14) 2014; 14
Robinson, McCarthy, Smyth (CR27) 2010; 26
Scaini (CR46) 2018; 28
Bar-Yosef (CR49) 2020; 10
Bortolasci (CR18) 2020
Du (CR13) 2014; 71
Martin, Morrison, Konstantopoulos, McGee (CR32) 2014; 3
Meng (CR24) 2019; 4
Brennand (CR41) 2015; 20
Chan, McCarthy, Vawter (CR44) 2020; 217
Ľupták, Fišar, Hroudová (CR51) 2021; 58
Choi (CR15) 2009; 9
Prabakaran (CR34) 2004; 9
Hjelm (CR9) 2015; 1
Mısır, Akay (CR3) 2023
Rajasekaran, Venkatasubramanian, Berk, Debnath (CR6) 2015; 48
Jiang (CR54) 2022; 13
(CR1) 2017; 390
Martínez-Reyes, Chandel (CR52) 2020; 11
Rosenfeld, Brenner-Lavie, Ari, Kavushansky, Ben-Shachar (CR50) 2011; 69
De Simone (CR4) 2023; 12
Roberts (CR8) 2021; 56
Panizzutti (CR19) 2021; 22
Iwamoto, Bundo, Kato (CR38) 2005; 14
Yu, Wang, Han, He (CR30) 2012; 16
Rollins (CR48) 2018; 3
Laursen, Nordentoft, Mortensen (CR2) 2014; 10
Nehme (CR11) 2022; 13
Manatt, Chandra (CR5) 2011; 3
Cui (CR53) 2021; 20
Berk (CR16) 2008; 64
Altar (CR37) 2005; 58
CR28
Martins-de-Souza (CR42) 2012; 2
CR26
Townsend (CR35) 2022
Melbourne (CR23) 2020; 79
Da Silveira Paulsen (CR39) 2012; 21
Devaraju (CR12) 2017; 22
Liu (CR21) 2022; 23
Subramanian (CR31) 2005; 102
C Gonzalez-Liencres (1727_CR14) 2014; 14
D Martins-de-Souza (1727_CR42) 2012; 2
BL Rollins (1727_CR48) 2018; 3
T Bar-Yosef (1727_CR49) 2020; 10
S Kidnapillai (1727_CR22) 2018
A Rajasekaran (1727_CR6) 2015; 48
CD Pandya (1727_CR17) 2013; 46
Y Jiang (1727_CR54) 2022; 13
G Yu (1727_CR30) 2012; 16
S Chan (1727_CR44) 2020; 217
SD Martin (1727_CR33) 2019; 7
CA Altar (1727_CR37) 2005; 58
G Scaini (1727_CR46) 2018; 28
P Devaraju (1727_CR12) 2017; 22
H Brenner-Lavie (1727_CR43) 2008; 1777
L Shao (1727_CR36) 2008; 40
L Townsend (1727_CR35) 2022
G De Simone (1727_CR4) 2023; 12
A Subramanian (1727_CR31) 2005; 102
K Iwamoto (1727_CR38) 2005; 14
E Mısır (1727_CR3) 2023
Y Benjamini (1727_CR29) 1995; 57
GBD 2016 DALYs and HALE Collaborators (1727_CR1) 2017; 390
B Panizzutti (1727_CR19) 2021; 22
LG Babich (1727_CR45) 2016; 88
S Prabakaran (1727_CR34) 2004; 9
M Rosenfeld (1727_CR50) 2011; 69
AM Bolger (1727_CR25) 2014; 30
CC Bortolasci (1727_CR18) 2020
G Cui (1727_CR53) 2021; 20
SD Martin (1727_CR32) 2014; 3
K Mittal (1727_CR47) 2017; 187
M Manatt (1727_CR5) 2011; 3
MD Robinson (1727_CR27) 2010; 26
TM Laursen (1727_CR2) 2014; 10
F Du (1727_CR13) 2014; 71
ZSJ Liu (1727_CR21) 2022; 23
B Da Silveira Paulsen (1727_CR39) 2012; 21
F Megiorni (1727_CR20) 2005; 373
M Ľupták (1727_CR51) 2021; 58
1727_CR26
O Robicsek (1727_CR40) 2013; 18
K Brennand (1727_CR41) 2015; 20
M Berk (1727_CR16) 2008; 64
T Singh (1727_CR10) 2022; 604
R Nehme (1727_CR11) 2022; 13
BE Hjelm (1727_CR9) 2015; 1
D Ben-Shachar (1727_CR7) 2002; 83
1727_CR28
KH Choi (1727_CR15) 2009; 9
JK Melbourne (1727_CR23) 2020; 79
Z Meng (1727_CR24) 2019; 4
RC Roberts (1727_CR8) 2021; 56
I Martínez-Reyes (1727_CR52) 2020; 11
References_xml – volume: 14
  start-page: 268
  year: 2014
  ident: CR14
  article-title: Oxidative stress in schizophrenia: a case-control study on the effects on social cognition and neurocognition
  publication-title: BMC Psychiatry
  doi: 10.1186/s12888-014-0268-x
– volume: 30
  start-page: 2114
  year: 2014
  end-page: 2120
  ident: CR25
  article-title: Trimmomatic: a flexible trimmer for Illumina sequence data
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btu170
– volume: 18
  start-page: 1067
  year: 2013
  end-page: 1076
  ident: CR40
  article-title: Abnormal neuronal differentiation and mitochondrial dysfunction in hair follicle-derived induced pluripotent stem cells of schizophrenia patients
  publication-title: Mol Psychiatry
  doi: 10.1038/mp.2013.67
– volume: 64
  start-page: 361
  year: 2008
  end-page: 368
  ident: CR16
  article-title: N-acetyl cysteine as a glutathione precursor for schizophrenia–a double-blind, randomized, placebo-controlled trial
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2008.03.004
– volume: 79
  year: 2020
  ident: CR23
  article-title: Treatment with the antipsychotic risperidone is associated with increased M1-like JAK-STAT1 signature gene expression in PBMCs from participants with psychosis and THP-1 monocytes and macrophages
  publication-title: Int Immunopharmacol
  doi: 10.1016/j.intimp.2019.106093
– volume: 26
  start-page: 139
  year: 2010
  end-page: 140
  ident: CR27
  article-title: edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btp616
– volume: 71
  start-page: 19
  year: 2014
  end-page: 27
  ident: CR13
  article-title: In vivo evidence for cerebral bioenergetic abnormalities in schizophrenia measured using 31P magnetization transfer spectroscopy
  publication-title: JAMA Psychiat
  doi: 10.1001/jamapsychiatry.2013.2287
– volume: 46
  start-page: 214
  year: 2013
  end-page: 223
  ident: CR17
  article-title: Antioxidants as potential therapeutics for neuropsychiatric disorders
  publication-title: Prog Neuropsychopharmacol Biol Psychiatry
  doi: 10.1016/j.pnpbp.2012.10.017
– year: 2020
  ident: CR18
  article-title: Effects of psychoactive drugs on cellular bioenergetic pathways
  publication-title: World J Biol Psychiatry
  doi: 10.1080/15622975.2020.1755450
– volume: 40
  start-page: 281
  year: 2008
  end-page: 295
  ident: CR36
  article-title: Mitochondrial involvement in psychiatric disorders
  publication-title: Ann Med
  doi: 10.1080/07853890801923753
– volume: 12
  start-page: 975
  year: 2023
  ident: CR4
  article-title: Schizophrenia synaptic pathology and antipsychotic treatment in the framework of oxidative and mitochondrial dysfunction: translational highlights for the clinics and treatment
  publication-title: Antioxidants (Basel)
  doi: 10.3390/antiox12040975
– volume: 22
  start-page: 1313
  year: 2017
  end-page: 1326
  ident: CR12
  article-title: Haploinsufficiency of the 22q11.2 microdeletion gene Mrpl40 disrupts short-term synaptic plasticity and working memory through dysregulation of mitochondrial calcium
  publication-title: Mol Psychiatry
  doi: 10.1038/mp.2016.75
– volume: 20
  start-page: 361
  year: 2015
  end-page: 368
  ident: CR41
  article-title: Phenotypic differences in hiPSC NPCs derived from patients with schizophrenia
  publication-title: Mol Psychiatry
  doi: 10.1038/mp.2014.22
– volume: 23
  start-page: 7180
  year: 2022
  ident: CR21
  article-title: Effects of psychotropic drugs on ribosomal genes and protein synthesis
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms23137180
– year: 2018
  ident: CR22
  article-title: The use of a gene expression signature and connectivity map to repurpose drugs for bipolar disorder
  publication-title: World J Biol Psychiatry
  doi: 10.1080/15622975.2018.1492734
– volume: 58
  start-page: 85
  year: 2005
  end-page: 96
  ident: CR37
  article-title: Deficient hippocampal neuron expression of proteasome, ubiquitin, and mitochondrial genes in multiple schizophrenia cohorts
  publication-title: Biol Psychiat
  doi: 10.1016/j.biopsych.2005.03.031
– volume: 390
  start-page: 1260
  year: 2017
  end-page: 1344
  ident: CR1
  article-title: Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  publication-title: Lancet
  doi: 10.1016/S0140-6736(17)32130-X
– volume: 22
  start-page: 7164
  year: 2021
  ident: CR19
  article-title: Transcriptional modulation of the hippo signaling pathway by drugs used to treat bipolar disorder and schizophrenia
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms22137164
– volume: 217
  start-page: 136
  year: 2020
  end-page: 147
  ident: CR44
  article-title: Psychiatric drugs impact mitochondrial function in brain and other tissues
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2019.09.007
– volume: 69
  start-page: 980
  year: 2011
  end-page: 988
  ident: CR50
  article-title: Perturbation in mitochondrial network dynamics and in complex I dependent cellular respiration in schizophrenia
  publication-title: Biol Psychiat
  doi: 10.1016/j.biopsych.2011.01.010
– volume: 14
  start-page: 241
  year: 2005
  end-page: 253
  ident: CR38
  article-title: Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/ddi022
– volume: 187
  start-page: 67
  year: 2017
  end-page: 73
  ident: CR47
  article-title: A comprehensive analysis of mitochondrial genes variants and their association with antipsychotic-induced weight gain
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2017.06.046
– volume: 10
  start-page: 12258
  year: 2020
  ident: CR49
  article-title: Mitochondrial function parameters as a tool for tailored drug treatment of an individual with psychosis: a proof of concept study
  publication-title: Sci Rep
  doi: 10.1038/s41598-020-69207-4
– volume: 28
  start-page: 369
  year: 2018
  end-page: 380
  ident: CR46
  article-title: Second generation antipsychotic-induced mitochondrial alterations: implications for increased risk of metabolic syndrome in patients with schizophrenia
  publication-title: Eur Neuropsychopharmacol
  doi: 10.1016/j.euroneuro.2018.01.004
– volume: 20
  start-page: 5010
  year: 2021
  end-page: 5023
  ident: CR53
  article-title: Salivary metabolomics reveals that metabolic alterations precede the onset of schizophrenia
  publication-title: J Proteome Res
  doi: 10.1021/acs.jproteome.1c00504
– volume: 3
  start-page: 408
  year: 2014
  end-page: 418
  ident: CR32
  article-title: Mitochondrial dysfunction has divergent, cell type-dependent effects on insulin action
  publication-title: Mol Metab
  doi: 10.1016/j.molmet.2014.02.001
– ident: CR26
– volume: 9
  start-page: 57
  year: 2009
  ident: CR15
  article-title: Effects of typical and atypical antipsychotic drugs on gene expression profiles in the liver of schizophrenia subjects
  publication-title: BMC Psychiatry
  doi: 10.1186/1471-244X-9-57
– volume: 88
  start-page: 5
  year: 2016
  end-page: 11
  ident: CR45
  article-title: Ca -dependent regulation of the Ca concentration in the myometrium mitochondria. I. Trifluoperazine effects on mitochondria membranes polarization and [Ca ]
  publication-title: Ukr Biochem J
  doi: 10.15407/ubj88.04.005
– volume: 3
  start-page: 157
  year: 2018
  end-page: 169
  ident: CR48
  article-title: Mitochondrial complex I deficiency in schizophrenia and bipolar disorder and medication influence
  publication-title: Mol Neuropsychiatry
– volume: 1777
  start-page: 173
  year: 2008
  end-page: 185
  ident: CR43
  article-title: Dopamine modulates mitochondrial function in viable SH-SY5Y cells possibly via its interaction with complex I: relevance to dopamine pathology in schizophrenia
  publication-title: Biochim Biophys Acta
  doi: 10.1016/j.bbabio.2007.10.006
– volume: 4
  year: 2019
  ident: CR24
  article-title: The atypical antipsychotic quetiapine induces hyperlipidemia by activating intestinal PXR signaling
  publication-title: JCI Insight
  doi: 10.1172/jci.insight.125657
– year: 2022
  ident: CR35
  article-title: Brain glucose metabolism in schizophrenia: a systematic review and meta-analysis of 18FDG-PET studies in schizophrenia
  publication-title: Psychol Med
  doi: 10.1017/S003329172200174X
– volume: 3
  start-page: 84
  issue: 5
  year: 2011
  end-page: 94
  ident: CR5
  article-title: The effects of mitochondrial dysfunction in schizophrenia
  publication-title: J Med Genet Genom
– volume: 13
  year: 2022
  ident: CR54
  article-title: Plasma metabolomics of schizophrenia with cognitive impairment: a pilot study
  publication-title: Front Psychiatry
  doi: 10.3389/fpsyt.2022.950602
– volume: 56
  start-page: 91
  year: 2021
  end-page: 101
  ident: CR8
  article-title: Mitochondrial dysfunction in schizophrenia: with a focus on postmortem studies
  publication-title: Mitochondrion
  doi: 10.1016/j.mito.2020.11.009
– volume: 11
  start-page: 102
  year: 2020
  ident: CR52
  article-title: Mitochondrial TCA cycle metabolites control physiology and disease
  publication-title: Nat Commun
  doi: 10.1038/s41467-019-13668-3
– volume: 21
  start-page: 1547
  year: 2012
  end-page: 1559
  ident: CR39
  article-title: Altered oxygen metabolism associated to neurogenesis of induced pluripotent stem cells derived from a schizophrenic patient
  publication-title: Cell Transplant
  doi: 10.3727/096368911X600957
– volume: 83
  start-page: 1241
  year: 2002
  end-page: 1251
  ident: CR7
  article-title: Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine
  publication-title: J Neurochem
  doi: 10.1046/j.1471-4159.2002.01263.x
– volume: 13
  start-page: 3690
  year: 2022
  ident: CR11
  article-title: The 22q11.2 region regulates presynaptic gene-products linked to schizophrenia
  publication-title: Nat Commun
  doi: 10.1038/s41467-022-31436-8
– volume: 48
  start-page: 10
  year: 2015
  end-page: 21
  ident: CR6
  article-title: Mitochondrial dysfunction in schizophrenia: pathways, mechanisms and implications
  publication-title: Neurosci Biobehav Rev
  doi: 10.1016/j.neubiorev.2014.11.005
– volume: 10
  start-page: 425
  year: 2014
  end-page: 448
  ident: CR2
  article-title: Excess early mortality in schizophrenia
  publication-title: Annu Rev Clin Psychol
  doi: 10.1146/annurev-clinpsy-032813-153657
– volume: 1
  start-page: 201
  year: 2015
  end-page: 219
  ident: CR9
  article-title: Evidence of mitochondrial dysfunction within the complex genetic etiology of schizophrenia
  publication-title: Mol Neuropsychiatry
– volume: 373
  start-page: 105
  year: 2005
  end-page: 109
  ident: CR20
  article-title: Expression of neuronal markers during NTera2/cloneD1 differentiation by cell aggregation method
  publication-title: Neurosci Lett
  doi: 10.1016/j.neulet.2004.09.070
– volume: 7
  start-page: 12
  year: 2019
  ident: CR33
  article-title: A systematic flux analysis approach to identify metabolic vulnerabilities in human breast cancer cell lines
  publication-title: Cancer Metab
  doi: 10.1186/s40170-019-0207-x
– year: 2023
  ident: CR3
  article-title: Synaptic dysfunction in schizophrenia
  publication-title: Synapse
  doi: 10.1002/syn.22276
– volume: 16
  start-page: 284
  year: 2012
  end-page: 287
  ident: CR30
  article-title: clusterProfiler: an R Package for comparing biological themes among gene clusters
  publication-title: OMICS J Integr Biol
  doi: 10.1089/omi.2011.0118
– volume: 57
  start-page: 289
  year: 1995
  end-page: 300
  ident: CR29
  article-title: Controlling the false discovery rate: a practical and powerful approach to multiple testing
  publication-title: J R Stat Soc Ser B (Methodol)
  doi: 10.1111/j.2517-6161.1995.tb02031.x
– volume: 102
  start-page: 15545
  year: 2005
  end-page: 15550
  ident: CR31
  article-title: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0506580102
– ident: CR28
– volume: 9
  start-page: 684
  year: 2004
  end-page: 697
  ident: CR34
  article-title: Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress
  publication-title: Mol Psychiatry
  doi: 10.1038/sj.mp.4001511
– volume: 604
  start-page: 509
  year: 2022
  end-page: 516
  ident: CR10
  article-title: Rare coding variants in ten genes confer substantial risk for schizophrenia
  publication-title: Nature
  doi: 10.1038/s41586-022-04556-w
– volume: 2
  year: 2012
  ident: CR42
  article-title: Identification of proteomic signatures associated with depression and psychotic depression in post-mortem brains from major depression patients
  publication-title: Transl Psychiatry
  doi: 10.1038/tp.2012.13
– volume: 58
  start-page: 5548
  year: 2021
  end-page: 5563
  ident: CR51
  article-title: Effect of novel antipsychotics on energy metabolism—in vitro study in pig brain mitochondria
  publication-title: Mol Neurobiol
  doi: 10.1007/s12035-021-02498-4
– volume: 46
  start-page: 214
  year: 2013
  ident: 1727_CR17
  publication-title: Prog Neuropsychopharmacol Biol Psychiatry
  doi: 10.1016/j.pnpbp.2012.10.017
– volume: 20
  start-page: 5010
  year: 2021
  ident: 1727_CR53
  publication-title: J Proteome Res
  doi: 10.1021/acs.jproteome.1c00504
– volume: 14
  start-page: 268
  year: 2014
  ident: 1727_CR14
  publication-title: BMC Psychiatry
  doi: 10.1186/s12888-014-0268-x
– volume: 56
  start-page: 91
  year: 2021
  ident: 1727_CR8
  publication-title: Mitochondrion
  doi: 10.1016/j.mito.2020.11.009
– volume: 12
  start-page: 975
  year: 2023
  ident: 1727_CR4
  publication-title: Antioxidants (Basel)
  doi: 10.3390/antiox12040975
– volume: 10
  start-page: 425
  year: 2014
  ident: 1727_CR2
  publication-title: Annu Rev Clin Psychol
  doi: 10.1146/annurev-clinpsy-032813-153657
– volume: 48
  start-page: 10
  year: 2015
  ident: 1727_CR6
  publication-title: Neurosci Biobehav Rev
  doi: 10.1016/j.neubiorev.2014.11.005
– year: 2022
  ident: 1727_CR35
  publication-title: Psychol Med
  doi: 10.1017/S003329172200174X
– volume: 16
  start-page: 284
  year: 2012
  ident: 1727_CR30
  publication-title: OMICS J Integr Biol
  doi: 10.1089/omi.2011.0118
– volume: 13
  year: 2022
  ident: 1727_CR54
  publication-title: Front Psychiatry
  doi: 10.3389/fpsyt.2022.950602
– year: 2018
  ident: 1727_CR22
  publication-title: World J Biol Psychiatry
  doi: 10.1080/15622975.2018.1492734
– volume: 13
  start-page: 3690
  year: 2022
  ident: 1727_CR11
  publication-title: Nat Commun
  doi: 10.1038/s41467-022-31436-8
– volume: 58
  start-page: 5548
  year: 2021
  ident: 1727_CR51
  publication-title: Mol Neurobiol
  doi: 10.1007/s12035-021-02498-4
– volume: 604
  start-page: 509
  year: 2022
  ident: 1727_CR10
  publication-title: Nature
  doi: 10.1038/s41586-022-04556-w
– volume: 69
  start-page: 980
  year: 2011
  ident: 1727_CR50
  publication-title: Biol Psychiat
  doi: 10.1016/j.biopsych.2011.01.010
– volume: 28
  start-page: 369
  year: 2018
  ident: 1727_CR46
  publication-title: Eur Neuropsychopharmacol
  doi: 10.1016/j.euroneuro.2018.01.004
– year: 2023
  ident: 1727_CR3
  publication-title: Synapse
  doi: 10.1002/syn.22276
– volume: 23
  start-page: 7180
  year: 2022
  ident: 1727_CR21
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms23137180
– volume: 1
  start-page: 201
  year: 2015
  ident: 1727_CR9
  publication-title: Mol Neuropsychiatry
– volume: 18
  start-page: 1067
  year: 2013
  ident: 1727_CR40
  publication-title: Mol Psychiatry
  doi: 10.1038/mp.2013.67
– volume: 217
  start-page: 136
  year: 2020
  ident: 1727_CR44
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2019.09.007
– volume: 9
  start-page: 684
  year: 2004
  ident: 1727_CR34
  publication-title: Mol Psychiatry
  doi: 10.1038/sj.mp.4001511
– volume: 20
  start-page: 361
  year: 2015
  ident: 1727_CR41
  publication-title: Mol Psychiatry
  doi: 10.1038/mp.2014.22
– volume: 11
  start-page: 102
  year: 2020
  ident: 1727_CR52
  publication-title: Nat Commun
  doi: 10.1038/s41467-019-13668-3
– volume: 40
  start-page: 281
  year: 2008
  ident: 1727_CR36
  publication-title: Ann Med
  doi: 10.1080/07853890801923753
– volume: 1777
  start-page: 173
  year: 2008
  ident: 1727_CR43
  publication-title: Biochim Biophys Acta
  doi: 10.1016/j.bbabio.2007.10.006
– ident: 1727_CR26
  doi: 10.1093/bioinformatics/bts635
– volume: 88
  start-page: 5
  year: 2016
  ident: 1727_CR45
  publication-title: Ukr Biochem J
  doi: 10.15407/ubj88.04.005
– volume: 10
  start-page: 12258
  year: 2020
  ident: 1727_CR49
  publication-title: Sci Rep
  doi: 10.1038/s41598-020-69207-4
– volume: 26
  start-page: 139
  year: 2010
  ident: 1727_CR27
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btp616
– ident: 1727_CR28
– volume: 373
  start-page: 105
  year: 2005
  ident: 1727_CR20
  publication-title: Neurosci Lett
  doi: 10.1016/j.neulet.2004.09.070
– volume: 71
  start-page: 19
  year: 2014
  ident: 1727_CR13
  publication-title: JAMA Psychiat
  doi: 10.1001/jamapsychiatry.2013.2287
– year: 2020
  ident: 1727_CR18
  publication-title: World J Biol Psychiatry
  doi: 10.1080/15622975.2020.1755450
– volume: 4
  year: 2019
  ident: 1727_CR24
  publication-title: JCI Insight
  doi: 10.1172/jci.insight.125657
– volume: 21
  start-page: 1547
  year: 2012
  ident: 1727_CR39
  publication-title: Cell Transplant
  doi: 10.3727/096368911X600957
– volume: 30
  start-page: 2114
  year: 2014
  ident: 1727_CR25
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btu170
– volume: 187
  start-page: 67
  year: 2017
  ident: 1727_CR47
  publication-title: Schizophr Res
  doi: 10.1016/j.schres.2017.06.046
– volume: 9
  start-page: 57
  year: 2009
  ident: 1727_CR15
  publication-title: BMC Psychiatry
  doi: 10.1186/1471-244X-9-57
– volume: 2
  year: 2012
  ident: 1727_CR42
  publication-title: Transl Psychiatry
  doi: 10.1038/tp.2012.13
– volume: 58
  start-page: 85
  year: 2005
  ident: 1727_CR37
  publication-title: Biol Psychiat
  doi: 10.1016/j.biopsych.2005.03.031
– volume: 3
  start-page: 84
  issue: 5
  year: 2011
  ident: 1727_CR5
  publication-title: J Med Genet Genom
– volume: 3
  start-page: 408
  year: 2014
  ident: 1727_CR32
  publication-title: Mol Metab
  doi: 10.1016/j.molmet.2014.02.001
– volume: 14
  start-page: 241
  year: 2005
  ident: 1727_CR38
  publication-title: Hum Mol Genet
  doi: 10.1093/hmg/ddi022
– volume: 7
  start-page: 12
  year: 2019
  ident: 1727_CR33
  publication-title: Cancer Metab
  doi: 10.1186/s40170-019-0207-x
– volume: 3
  start-page: 157
  year: 2018
  ident: 1727_CR48
  publication-title: Mol Neuropsychiatry
– volume: 79
  year: 2020
  ident: 1727_CR23
  publication-title: Int Immunopharmacol
  doi: 10.1016/j.intimp.2019.106093
– volume: 64
  start-page: 361
  year: 2008
  ident: 1727_CR16
  publication-title: Biol Psychiatry
  doi: 10.1016/j.biopsych.2008.03.004
– volume: 57
  start-page: 289
  year: 1995
  ident: 1727_CR29
  publication-title: J R Stat Soc Ser B (Methodol)
  doi: 10.1111/j.2517-6161.1995.tb02031.x
– volume: 83
  start-page: 1241
  year: 2002
  ident: 1727_CR7
  publication-title: J Neurochem
  doi: 10.1046/j.1471-4159.2002.01263.x
– volume: 22
  start-page: 7164
  year: 2021
  ident: 1727_CR19
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms22137164
– volume: 102
  start-page: 15545
  year: 2005
  ident: 1727_CR31
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.0506580102
– volume: 22
  start-page: 1313
  year: 2017
  ident: 1727_CR12
  publication-title: Mol Psychiatry
  doi: 10.1038/mp.2016.75
– volume: 390
  start-page: 1260
  year: 2017
  ident: 1727_CR1
  publication-title: Lancet
  doi: 10.1016/S0140-6736(17)32130-X
SSID ssj0001520
Score 2.433366
Snippet Schizophrenia (SCZ) is a complex neuropsychiatric disorder associated with altered bioenergetic pathways and mitochondrial dysfunction. Antipsychotic...
SourceID proquest
gale
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1125
SubjectTerms Allosteric properties
Analysis
Antipsychotic drugs
Antipsychotics
Aripiprazole
Bioenergetics
Clozapine
Drug metabolism
Drugs
Energy metabolism
Enzymatic activity
Gas chromatography
Gene expression
Genes
Glycolysis
Health aspects
Mass spectrometry
Mass spectroscopy
Medicine
Medicine & Public Health
Mental disorders
Metabolism
Metabolites
Metabolomics
Mitochondria
Nervous system diseases
Neurosciences
Original Paper
Oxidative phosphorylation
Phosphorylation
Post-transcription
Post-translation
Psychiatry
Psychotropic drugs
Risperidone
Schizophrenia
Therapeutic applications
Tricarboxylic acid cycle
SummonAdditionalLinks – databaseName: SpringerLink Journals (ICM)
  dbid: U2A
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9wwDBelg7KXsY92y9aWDAZ7aAMXfyTx4zFWyqB72kHfjC0746DNjebu_5-UONmubIO9xh84kizJlvQzwAcfqiBMbApfY1Oo1rjCqBILqVt0vjVtiXzfcfO1ul6pL7f6NhWF9VO2-xSSHDT1XOzG8sYJs5z_Q1a3IMX7RPPZnaR4JZaz_iWLNNysGI5aSqlSqcyf59gzR4-V8m9W6VGYdLA-V8_hWXIb8-XI5xdwELuXcHSTAuOvQI4oxH2-aXOi1ToVV60xDw-77_S5y-NQ5Zffxy3x_W7d3x_D6urzt0_XRXoPoUClxLYQUqNX2mkkpdSWsgxBuap2Eb2XpcbofaO0Z1A_rdt6YYIvUTlZE81VkFGewGG36eIbyBmFLVYoRGyCqgJ6sWhJ7bnamzqi0xmUE1ksJrBwfrPizs4wxwMpLZHSDqS0IoOLecyPESrjn70_MrUt7yOaGV0qB6D1MSKVXbInWzG-VQanez1J_nG_eeKXTfuvt5IDjo02osrg_dzMIzmnrIubXW-FWZCvUxvdZPB65PO8bobhF01VZ3A5Mf7X5H__qbf_1_0dPCX5VWM-4Skcbh928Yx8nK0_H0T6J0_T7v0
  priority: 102
  providerName: Springer Nature
Title Effects of antipsychotic drugs on energy metabolism
URI https://link.springer.com/article/10.1007/s00406-023-01727-2
https://www.ncbi.nlm.nih.gov/pubmed/38072867
https://www.proquest.com/docview/3076085926
https://www.proquest.com/docview/2902937958
Volume 274
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9QwDLdge-EFMfFVGFMnIfEAEdd8NM0TuqHbJhATQpx0PEWNk6KTtt5Y7_5_4jbXcZPYU6U0iVLbsd3Y_gXgrfOl5yZUzGmsmGxMzYwskAnVYO0a0xRI5x3fLsrzufyyUIt04NaltMqtTuwVtV8hnZF_FBRCqpTh5afrP4xujaLoarpC4yHsE3QZpXTpxfjDFS3dAMtoKH4phExFM33pHEkvpd9SNlG04YzvGKa76vkf-3QnYNrbodMn8Dg5kPl04PgBPAjtUxADCHGXr5o8kmqZaquWmPubze_Y3OahL_LLr8I6sv1y2V09g_np7Ofnc5auQ2AoJV8zLhQ6qWqFUSc1hSi8l3Wp64DOiUJhcK6SyhGmn1KNnhjvCpS10JHk0osgnsNeu2rDS8gJhC2UyHmovCw9Oj5potartTM6YK0yKLa0sJiwwunKiks7ohz39LORfrann-UZvB_HXA9IGff2fkcktrSN4sxYp2qAuD4CpLJTcmRLgrfK4HCnZxR_3H29ZZJN26-zt8KSwfH4mkZSSlkbVpvOcjOJro6OUpPBi4G547oJhZ9Xpc7gw5bbt5P__6Ne3b-W1_CIR5doSB88hL31zSa8iS7N2h31cnsE-9OzX19n8Xkyu_j-I7bO-fQvNYbzEg
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6V7QEuqIhXoECQQBzAYuNHEh8QKtBqS9sVQq3Um4kfQSu12bbZFeJP8RuZyatsJXrrNX7ImYdn7Jn5DPDK-tRzHXJmM5czWeqCaZk4JlTpClvqMnF033EwTSdH8uuxOl6DP30tDKVV9ntis1H7uaM78veCQki50jz9eHbO6NUoiq72T2i0YrEXfv_CI1v9YfcL8vc15zvbh58nrHtVgDkp-YJxoZyVqlAOVbtMROK9LNKsCM5akSgXrM2lsgSNp1SZjbW3iZOFyHDl0osgcN5bsC4FHmVGsP5pe_rt-7D3ozVsbnU0RUyFkF2ZTlOsR_pCCb-Uv4ReA-MrpvCqQfjHIl4J0TaWb2cD7nYua7zVytg9WAvVfRAt7HEdz8sYmTPrqrlmLvYXy5_4uYpDU1YYn4YFCtrJrD59AEc3QqqHMKrmVXgMMcG-hdRxHnIvU-8sH5e4zxaZ1VlwhYog6WlhXIdOTo9knJgBV7mhn0H6mYZ-hkfwdhhz1mJzXNv7DZHYkOLizK7o6g9wfQSBZbbIdU4JUCuCzZWeqHButblnkukUvjaX4hnBy6GZRlISWxXmy9pwPUbnKtMqj-BRy9xh3YT7z_M0i-Bdz-3Lyf__U0-uX8sLuD05PNg3-7vTvadwh6ND1iYvbsJocbEMz9ChWtjnnRTH8OOmFecvo0MvDw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIiEuCMQrUCBIIA4QdeNHHB8QqiirlkLFgUp7M_GrWqnNlmZXiL_Gr2Mmr7KV6K3XOLbseXjG9sw3AK-sLzzTocyscmUmoq4yLXKXcRldZaOOuaP7jq-Hxd6R-DyTsw34M-TCUFjlsCe2G7VfOLoj3-b0hFRKzYrt2IdFfNudfjj7mVEFKXppHcppdCJyEH7_wuNb835_F3n9mrHpp-8f97K-wkDmhGDLjHHprJCVdKjmMee596IqVBWctTyXLlhbCmkJJk_KqCba29yJiitchfA8cBz3BtxUXOakY2o2HvbQynaQkJreTjkXfcJOm7ZHmkOhvxTJhP5DxtaM4mXT8I9tvPRY29rA6V240zuv6U4nbfdgI9T3gXcAyE26iCmyad7ndc1d6s9Xx_i5TkObYJiehiWK3Mm8OX0AR9dCqIewWS_q8BhSAoALhWMslF4U3lk2ibjjVspqFVwlE8gHWhjX45RTuYwTMyIst_QzSD_T0s-wBN6Ofc46lI4r_35DJDakwjiyq_pMBJwfgWGZHXKiC4LWSmBr7U9UPbfePDDJ9KrfmAtBTeDl2Ew9KZytDotVY5ieoJultCwTeNQxd5w3VQBgZaESeDdw-2Lw_y_qydVzeQG3UF3Ml_3Dg6dwm6Fn1kUxbsHm8nwVnqFntbTPWxFO4cd168xfp_sx3w
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+antipsychotic+drugs+on+energy+metabolism&rft.jtitle=European+archives+of+psychiatry+and+clinical+neuroscience&rft.au=Panizzutti%2C+Bruna&rft.au=Bortolasci%2C+Chiara+C&rft.au=Spolding%2C+Briana&rft.au=Kidnapillai%2C+Srisaiyini&rft.date=2024-08-01&rft.issn=1433-8491&rft.eissn=1433-8491&rft.volume=274&rft.issue=5&rft.spage=1125&rft_id=info:doi/10.1007%2Fs00406-023-01727-2&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0940-1334&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0940-1334&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0940-1334&client=summon